Perspectives on Anti-BCMA Bispecific Antibodies use in Multiple Myeloma–Experience from Asian Countries
The insights gained will contribute to developing strategic frameworks and consensus guidelines that can effectively guide clinicians in optimizing outcomes for myeloma patients in diverse healthcare settings.
Authors
- Cinnie Yentia Soekojo (ORCID: https://orcid.org/0000-0001-8376-8872)
- Daryl Tan (ORCID: https://orcid.org/0000-0003-2430-3308)
- Jeffrey Huang
- Kazuhito Suzuki (ORCID: https://orcid.org/0000-0002-0300-378X)
- Hiroyuki Takamatsu (ORCID: https://orcid.org/0000-0001-9515-0017)
- Uday Yanamandra (ORCID: https://orcid.org/0000-0002-0546-6585)
- Shimin Jasmine Chung (ORCID: https://orcid.org/0000-0002-5174-7361)
- Dong‐Gun Lee (ORCID: https://orcid.org/0000-0003-4655-0641)
- Wee Joo Chng (ORCID: https://orcid.org/0000-0003-2578-8335)
- Ming‐Han Tsai
- Chandramouli Nagarajan (ORCID: https://orcid.org/0000-0001-5755-2226)
- S. Subramanian (ORCID: https://orcid.org/0000-0001-7971-6842)
- Wen-Ming Chen (ORCID: https://orcid.org/0000-0001-9070-9280)
- Jin Seok Kim (ORCID: https://orcid.org/0000-0001-8986-8436)
- Chang Ki Min
Institutions
- Jikei University School of Medicine (JP)
- Capital Medical University (CN)
- Yonsei University (KR)
- Singapore General Hospital (SG)
- Apollo Gleneagles Hospitals (IN)
- Gleneagles Hospital (SG)
- Mount Elizabeth Novena Hospital (SG)
- National University Cancer Institute, Singapore (SG)
- Kanazawa University Hospital (JP)
- National Taiwan University Hospital (TW)
- National Cancer Centre Singapore (SG)
- Armed Forces Medical College (IN)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Clinical Lymphoma Myeloma & Leukemia
- Published
- 2025-10-11
- DOI
- https://doi.org/10.1016/j.clml.2025.10.005
- Primary Topic
- Complement system in diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00